| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-13 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |